About David Parry
Form D filings for Sedare Biosciences in 2024 list David Parry as president and director.
David Parry first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name David Parry in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Parry works with at each company, as listed on that company's latest Form D.
Sedare Biosciences, Inc. · Form D, Jan 23, 2024
CR
Christian Richard
Director
DM
Donald McCarthy
Executive officer and director
RR
Ravichandran Rao
Executive officer